Aytu Biopharma Inc (NASDAQ:AYTU)

Delayed Data
As of Sep 24
 -0.05 / -1.66%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Aytu Biopharma Inc have a median target of 17.50, with a high estimate of 24.00 and a low estimate of 11.00. The median estimate represents a +491.22% increase from the last price of 2.96.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Aytu Biopharma Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Sep 27

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 70.92%
Growthannually 5.33%


Growthquarterly 83.20%
Growthannually 139.40%
Key to the earnings and sales forecast charts.